Page last updated: 2024-08-25

zoledronic acid and technetium tc 99m medronate

zoledronic acid has been researched along with technetium tc 99m medronate in 7 studies

Research

Studies (7)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (28.57)	29.6817
2010's	5 (71.43)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barutca, S; Erdogan, S; Koseoglu, K; Meydan, N; Yurekli, Y	1
Biasotto, M; Cavalli, F; Chiandussi, S; Cova, MA; Di Lenarda, R; Dore, F	1
Divgi, C; Grewal, RK; Hudis, CA; Larson, S; Mak, AF; Modi, S; Morris, PG; Patil, S; Poznak, CV	1
Carrasquillo, J; Grewal, RK; Hudis, C; Larson, S; Morris, PG; Van Poznak, C	1
De La Cueva, L; Liévano, P; López Vélez, L; Navarro, P; Rodríguez Chacón, L; Sanz Moncasi, P	1
Han, X; Liu, S; Sun, Z; Wu, C; Yang, S; Ye, Y	1
Cheng, W; Lin, J; Lv, G; Nan, B; Qiu, L	1

Trials

1 trial(s) available for zoledronic acid and technetium tc 99m medronate

Article	Year
Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan results. Clinical breast cancer, 2010, Volume: 10, Issue:1 Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Infusions, Intravenous; Jaw Diseases; Middle Aged; Osteonecrosis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Zoledronic Acid	2010

Article

Year

Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan results.

Clinical breast cancer, 2010, Volume: 10, Issue:1

Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Infusions, Intravenous; Jaw Diseases; Middle Aged; Osteonecrosis; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Medronate; Zoledronic Acid

2010

Other Studies

6 other study(ies) available for zoledronic acid and technetium tc 99m medronate

Article	Year
Reversible metastatic visceral calcification detected by 99mTc-methylene diphosphonate bone scanning in breast cancer. Journal of bone and mineral metabolism, 2005, Volume: 23, Issue:5 Topics: Antineoplastic Agents; Bone and Bones; Breast Neoplasms; Calcification, Physiologic; Calcium; Diphosphonates; Female; Heart Neoplasms; Humans; Imidazoles; Lung Neoplasms; Middle Aged; Neoplasm Metastasis; Stomach Neoplasms; Technetium Tc 99m Medronate; Thyroid Neoplasms; Time Factors; Zoledronic Acid	2005
Clinical and diagnostic imaging of bisphosphonate-associated osteonecrosis of the jaws. Dento maxillo facial radiology, 2006, Volume: 35, Issue:4 Topics: Aged; Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Jaw Diseases; Magnetic Resonance Imaging; Male; Middle Aged; Multiple Myeloma; Osteonecrosis; Radiography, Panoramic; Radionuclide Imaging; Retrospective Studies; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Zoledronic Acid	2006
Bone scans, bisphosphonates, and a lack of acute changes within the mandible. Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons, 2011, Volume: 69, Issue:1 Topics: Adult; Aged; Bone Density Conservation Agents; Bone Neoplasms; Diphosphonates; Female; Femur; Humans; Imidazoles; Infusions, Intravenous; Mandible; Middle Aged; Prospective Studies; Radionuclide Imaging; Radiopharmaceuticals; Single-Blind Method; Technetium Tc 99m Medronate; Thigh; Time Factors; Zoledronic Acid	2011
Gorham's disease: 99mTc HMDP bone scan findings. Revista espanola de medicina nuclear e imagen molecular, 2012, Volume: 31, Issue:5 Topics: Biopsy; Bone Density Conservation Agents; Bone Neoplasms; Calcinosis; Calcium; Diagnosis, Differential; Diphosphonates; Drug Therapy, Combination; Edema; Humans; Humerus; Imidazoles; Male; Middle Aged; Multimodal Imaging; Osteolysis, Essential; Positron-Emission Tomography; Radiopharmaceuticals; Sarcoma, Synovial; Scapula; Shoulder Joint; Technetium Tc 99m Medronate; Tomography, X-Ray Computed; Vitamin D; Zoledronic Acid	2012
Characterization of the attenuation of breast cancer bone metastasis in mice by zoledronic acid using (99m)Tc bone scintigraphy. Pathology oncology research : POR, 2014, Volume: 20, Issue:3 Topics: Animals; Biomarkers, Tumor; Blotting, Western; Bone Density Conservation Agents; Bone Neoplasms; Breast Neoplasms; Diphosphonates; Female; Humans; Imidazoles; Mice; Mice, Inbred BALB C; Mice, Nude; Radionuclide Imaging; Radiopharmaceuticals; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Technetium Tc 99m Medronate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays; Zoledronic Acid	2014
Pharmacokinetic and imaging evaluation of (99m)Tc-HBIDP as a potential bone imaging agent. Pakistan journal of pharmaceutical sciences, 2015, Volume: 28, Issue:3 Topics: Animals; Bone and Bones; Diphosphonates; Half-Life; Imidazoles; Mice; Organotechnetium Compounds; Rabbits; Radiopharmaceuticals; Technetium Tc 99m Medronate; Tomography, Emission-Computed, Single-Photon; Zoledronic Acid	2015